Zusammenfassung
Menschen mit Diabetes haben gegenüber der Allgemeinbevölkerung ein deutlich erhöhtes Risiko für die Entwicklung einer Depressivität (subklinische Depression) oder Depression (klinische Depression, entsprechen den ICD- bzw. DSM-Kriterien), welche eine bedeutsame Barriere für das Erreichen der Therapieziele des Diabetes darstellen. Diabetespatienten mit einer Depression weisen im Vergleich zu nichtdepressiven Patienten ein ungünstigeres Krankheits- und Therapieverhalten, eine eingeschränkte Lebensqualität, eine schlechtere Blutzuckereinstellung, ein erhöhtes Risiko für die Entwicklung von Folgeerkrankungen sowie auch ein deutlich erhöhtes Mortalitätsrisiko auf. Als Ursache hierfür werden sowohl neuroendokrinologische Veränderungen, krankheitsspezifische Belastungen, direkte wie indirekte Auswirkungen der Blutzuckerwerte auf die Stimmung als auch dysfunktionale Bewältigungsfertigkeiten und -stile seitens des Patienten diskutiert. Obwohl wirksame Interventionen zur Depressionsbehandlung bei Diabetespatienten zu Verfügung stehen, werden in der Praxis noch zu wenige Patienten mit einer Depressionen diagnostiziert und adäquat behandelt.
Abstract
Compared with the general population diabetic patients have a clearly increased risk of suffering from depressive symptoms (subclinical form) or to develop depression (according the ICD or DSM criteria), which can represent a significant barrier to achieving the goals of diabetes therapy. The co-morbidity of depression and diabetes has a negative impact on the patient’s disease management, quality of life, glycaemic control, risk for late complications and mortality. Neuroendocrine alterations, disease-specific impact, direct and indirect effects on glycaemic control as well as impaired coping ability and strategies are all discussed as possible causes. Although effective interventions for the management of depression in diabetic patients exist, in clinical practise, patients with depression remain to a large extent unrecognised and untreated.
Literatur
Moussavi S, Chatterji S, Verdes E et al (2007) Depression, chronic diseases and decrements in health: results from the World Health Surveys. Lancet 370(9590):851–858
Knol MJ, Twisk JW, Beekman AT et al (2006) Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 49(5):837–845
Mezuk B, Eaton WW, Albrecht S, Golden SH (2008) Depression and type 2 diabetes over the lifespan. Diabetes Care 31(12):2383–2390
Rubin RR, Ma Y, Marrero DG et al (2008) Elevated depression symptoms, antidepressant medicine use and risk of developing diabetes during the Diabetes Prevention Program. Diabetes Care 31(3):420–426
Andersohn F, Schade R, Suissa S, Garbe E (2009) Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. Am J Psychiatry 166(5):591–598
Anderson RJ, Freedland KE, Clouse RE, Lustman PJ (2001) The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24(6):1069–1078
Ali S, Stone MA, Peters JL et al (2006) The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med 23(11):1165–1173
Wittchen HU, Muller N, Pfister H et al (1999) Affektive, somatoforme und Angststörungen in Deutschland – Erste Ergebnisse des bundesweiten Zusatzsurveys „Psychische Störungen“ [Affective, somatoform and anxiety disorders in Germany–initial results of an additional federal survey of „psychiatric disorders“]. Gesundheitswesen 61 Spec No:S216–S222
Kruse J, Schmitz N, Thefeld W (2003) On the association between diabetes and mental disorders in a community sample: results from the German National Health Interview and Examination Survey. Diabetes Care 26(6):1841–1846
Hermanns N, Kubiak T, Krichbaum M et al (2003) Risikoprofil für affektive Störungen bei Diabetes mellitus. Diab Stoffw 12(Suppl 1):153
Hermanns N, Kulzer B, Krichbaum M et al (2005) Affective and anxiety disorders in a German sample of diabetic patients: prevalence, comorbidity and risk factors. Diabet Med 22(3):293–300
Egede LE (2004) Diabetes, major depression and functional disability among U.S. adults. Diabetes Care 27(2):421–428
Egede LE (2004) Effects of depression on work loss and disability bed days in individuals with diabetes. Diabetes Care 27(7):1751–1753
Goldney RD, Phillips PJ, Fisher LJ, Wilson DH (2004) Diabetes, depression and quality of life: a population study. Diabetes Care 27(5):1066–1070
Hermanns N, Kulzer B, Krichbaum M et al (2006) How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depression questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment. Diabetologia 49(3):469–477
Lustman PJ, Groot M de, Anderson RJ et al (2000) Depression and poor glycemic control. Diabetes Care 23:934–942
Richardson LK, Egede LE, Mueller M et al (2008) Longitudinal effects of depression on glycemic control in veterans with type 2 diabetes. Gen Hosp Psychiatry 30(6):509–514
Wagner J, Tsimikas J, Abbott G et al (2007) Racial and ethnic differences in diabetic patient-reported depression symptoms, diagnosis, and treatment. Diabetes Res Clin Pract 75(1):119–122
Lustman PJ, Anderson RJ, Freedland KE et al (2000) Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23(7):934–942
Black SA, Markides KS, Ray LA (2003) Depression predicts increased incidence of adverse health outcomes in older mexican Americans with type 2 diabetes. Diabetes Care 26(10):2822–2828
Heckbert SR, Rutter CM, Oliver M et al (2010) Depression in relation to long-term control of glycemia, blood pressure and lipids in patients with diabetes. J Gen Intern Med (in press)
Lin EH, Heckbert SR, Rutter CM et al (2009) Depression and increased mortality in diabetes: unexpected causes of death. Ann Fam Med 7(5):414–421
Zhang X, Norris SL, Gregg EW et al (2005) Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol 161(7):652–660
Katon WJ, Rutter C, Simon G et al (2005) The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care 28(11):2668–2672
Ciechanowski PS, Katon WJ, Russo JE (2000) Depression and diabetes: impact of depressive symptoms on adherence, function and costs. Arch Intern Med 160(21):3278–3285
Pieper L, Schulz H, Klotsche J et al (2008) Depression als komorbide Störung in der primärärztlichen Versorgung [Depression as a comorbid disorder in primary care]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 51(4):411–421
Pickup JC (2004) Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27(3):813–823
Snoek FJ, Pouwer F, Welch GW, Polonsky WH (2000) Diabetes related emotional stress in Dutch and US diabetic patients: cross-cultural validity of the problem areas in diabetes scale. Diabetes Care 23:1305–1309
Hermanns N, Kubiak T, Kulzer B, Haak T (2003) Emotional changes during experimentally induced hypoglycaemia in type 1 diabetes. Biol Psychol 63(1):15–44
Bode BW, Schwartz S, Stubbs HA, Block JE (2005) Glycemic characteristics in continuously monitored patients with type 1 and type 2 diabetes: normative values. Diabetes Care 28(10):2361–2366
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kulzer, B., Hermanns, N. & Kruse, J. Diabetes und Depression. Diabetologe 6, 255–265 (2010). https://doi.org/10.1007/s11428-009-0531-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11428-009-0531-9